STAT+: Experts scrutinize Huidagene’s disclosures after patient death
Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 283 articles · page 5 of 8 · fetched 22 minutes ago
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
Read at source →
STAT+: American Cancer Society cancels alcohol industry fundraiser
The American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
STAT+: Brain organoids, kept alive more than five years, matured like human brains
Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic…
Read at source →
STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more
President Trump is expected to nominate Heidi Overton, White House deputy director of domestic policy, to serve as the…
Read at source →
Dissecting Chinese trial strategy in wake of deaths
Cancer "vaccine" successfully slowed melanoma, dissecting Chinese trial strategy in wake of deaths, and more health…
Read at source →
STAT+: What Epic did — and didn’t — say about AI at its annual meeting
At Epic's annual meeting, the prevailing question behind closed doors is “What the heck is going on with Epic?”
Read at source →
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful…
Read at source →
Accrediting body considers changes to racism curriculum standards for public health schools
The accrediting group for schools of public health is weighing the removal of language that specifically requires…
Read at source →
STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions
Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy…
Read at source →
Opinion: I’m a pediatrician. AI chatbots are grooming my patients
“At present, the law does not recognize that child abuse is child abuse when it’s perpetrated by an algorithm operated…
Read at source →
She grew up unvaccinated. Now she’s a leading voice for science — and empathy
Immunologist Liz Marnik, who grew up unvaccinated, says shaming people who distrust science will do nothing to improve…
Read at source →
Opinion: AI has created a shadow medical system
Financial incentives – health care makes up nearly one-fifth of the American economy – have driven every major AI…
Read at source →
Physician group sues Trump administration over dietary guidelines process
The suit, brought by a nonprofit that advocates for plant-based diets, claims HHS and the USDA used a “secret panel” of…
Read at source →
STAT+: Trump expected to pick White House adviser Heidi Overton to lead FDA
Heidi Overton, a doctor and White House adviser, is expected to be President Trump's pick to lead the FDA.
Read at source →
Fauci adviser David Morens pleads guilty to avoiding records requests, conspiracy to defraud government
Morens said he had agreed to work to avoid public disclosures and to use his influence to advance a company's interests.
Read at source →
STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm
Private equity firms have taken a strong interest in revenue cycle management firms, such as Ensemble.
Read at source →
Trump administration sued over visa time limit that would affect grad students, postdocs
DHS was sued Tuesday over a sweeping policy change that would limit how long foreign students and scholars can remain…
Read at source →
STAT+: The White House declares ‘promises made, promises kept’ on lowering drug prices. Nice try
In its effort to lower drug prices, the White House has declared "promises made, promises kept." That's a narrative…
Read at source →
STAT+: Real-world psilocybin data suggest need for close monitoring
Amylyx reports success in a pivotal trial, biopharma A-listers join a pain-blocking device company board, and more…
Read at source →
STAT+: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024
Top executives of major health systems got substantial raises, even as their hospitals grappled with plenty of…
Read at source →
STAT+: Government workers feel the squeeze on health care
Municipalities are struggling with the cost of health insurance for their workers, and states are facing a major…
Read at source →STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell…
Read at source →
Kindergarten vaccine exemptions are climbing
Doritos as "real" "food," public-sector health care in trouble, and more health news from Morning Rounds
Read at source →
STAT+: Prominent AI startup rolls out virtual cell model in race to speed up science
A prominent AI startup has rolled out a virtual cell model, advancing the race to speed up science.
Read at source →
STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricing
Lilly was accused of charging “grossly” excessive prices for different insulin products that forced some patients to…
Read at source →
STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.
Read at source →STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
An FDA advisory panel recommended use of an experimental Replimune treatment for advanced melanoma that the agency has…
Read at source →
STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent…
Read at source →
Federal government could improve infectious disease monitoring, says federal government
The new CDC director nominee moves to the full Senate vote, Medicaid work requirements will not be delayed, and more…
Read at source →
Opinion: We once praised the American Diabetes Association’s courage. How things have changed
“The ADA is no longer what we’d call a profile in courage,” write Adam Marcus and Ivan Oransky of Retraction Watch.
Read at source →
Opinion: Limb girdle muscular dystrophy patients face a maddening reality
“Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that…
Read at source →
Opinion: What a recent op-ed got wrong about our Covid study
“The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.”
Read at source →
Syphilis spreads while researchers contend with federal constraints and a drug shortage
At the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug…
Read at source →
Capricor’s data clash and a fugitive in the C-suite
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their…
Read at source →
Key Senate panel backs Trump’s picks for CDC, pandemic preparedness
In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to…
Read at source →